Scanned by

    Norton

    Norton™ Safe Web

    Screening for, Assessing, and Diagnosing DMD

    Screening for, Assessing, and Diagnosing DMD

    06:57 |
    Download Here

    You Might Also Like:

    The France Foundation

    The France Foundation

    4:14 |
    The France Foundation - IPF Management In Practice

    The France Foundation - IPF Management In Practice

    1:59 |
    Cleveland Clinic Tall Rounds: Treating Confirmed ATTR

    Cleveland Clinic Tall Rounds: Treating Confirmed ATTR

    59:35 |
    What do you Know About RSV in Adults

    What do you Know About RSV in Adults

    3:19 |
    Addressing DMD Time to Diagnosis - Impact of Early Diagnosis

    Addressing DMD Time to Diagnosis - Impact of Early Diagnosis

    8:06 |
    Practice Improvement through ILD Centers and Community Partnerships: The France foundation

    Practice Improvement through ILD Centers and Community Partnerships: The France foundation

    3:13 |
    Engaging the Patient in Treatment Choices

    Engaging the Patient in Treatment Choices

    17:29 |
    The Role of Pediatricians in Managing Patients with DMD

    The Role of Pediatricians in Managing Patients with DMD

    4:13 |
    The French-American Foundation - Young Leaders Program

    The French-American Foundation - Young Leaders Program

    6:06 |
    Screening for, Assessing, and Diagnosing DMD

    Screening for, Assessing, and Diagnosing DMD

    6:57 |
    Addressing DMD Time to Diagnosis - First Clinical Suspicion

    Addressing DMD Time to Diagnosis - First Clinical Suspicion

    6:53 |
    City of Hope Collaboration

    City of Hope Collaboration

    5:03 |
    Addressing DMD Time to Diagnosis - Obstacles to Diagnosis

    Addressing DMD Time to Diagnosis - Obstacles to Diagnosis

    7:17 |
    Addressing DMD Time to Diagnosis - Consequences of Delayed Diagnosis

    Addressing DMD Time to Diagnosis - Consequences of Delayed Diagnosis

    5:11 |
    Delayed Diagnosis of SSc ILD with PPF

    Delayed Diagnosis of SSc ILD with PPF

    20:00 |
    Pulmonary Arterial Hypertension (PAH): How to Develop an Effective Risk Reduction Strategy

    Pulmonary Arterial Hypertension (PAH): How to Develop an Effective Risk Reduction Strategy

    4:08 |
    Immune Thrombocytopenic Purpura (iTTP) Panel Discussion: Delay in Diagnosis - Why?

    Immune Thrombocytopenic Purpura (iTTP) Panel Discussion: Delay in Diagnosis - Why?

    9:22 |
    Fabry Disease in Females

    Fabry Disease in Females

    2:57 |
    SmithBucklin Corporation

    SmithBucklin Corporation

    4:22 |
    Immune Thrombocytopenic Purpura (iTTP) Panel Discussion: Multidisciplinary Collaboration

    Immune Thrombocytopenic Purpura (iTTP) Panel Discussion: Multidisciplinary Collaboration

    3:02 |